Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a treatment called stellate ganglion block, which involves numbing certain nerves in the neck. It aims to help people who have lost their sense of smell and have other long-term symptoms after COVID-19. The treatment works by calming overactive nerve signals to improve these persistent issues.
Do I need to stop my current medications for the trial?
The trial requires that you stop taking blood thinners or antiplatelet agents. Other medications are not specifically mentioned, so it's best to discuss with the trial team.
Is Stellate Ganglion Block (SGB) generally safe for humans?
Stellate Ganglion Block (SGB) is generally considered a safe procedure, but in rare cases, it can lead to serious complications like retropharyngeal hematomas (a type of throat bleeding) and toxicity from the anesthetics used. These complications require specific management and preventive measures.12345
How is Stellate Ganglion Block (SGB) treatment different from other treatments?
Stellate Ganglion Block (SGB) is unique because it blocks sympathetic nerve signals, which can help control conditions like refractory ventricular arrhythmias that don't respond to other treatments. Unlike many treatments that focus on pain relief, SGB is also being explored for various non-pain conditions, making it a versatile option.12567
What data supports the effectiveness of the treatment Stellate Ganglion Block (SGB)?
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive sequential stellate ganglion blocks to treat COVID-19-induced olfactory dysfunction and other long COVID symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Stellate Ganglion Block
Stellate Ganglion Block is already approved in United States for the following indications:
- Chronic pain management
- Posttraumatic stress disorder (PTSD) symptoms reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor